1 回答
Yes, HBELs should be established for all medicinal products. The toxicological or pharmacological data, on which the HBEL calculation relies, requires periodical re- assessment throughout a product’s lifecycle.
是的,应为所有药品建立HBEL。HBEL计算所依赖的毒性或药学数据需要在产品生命周期内定期进行重新评估。